PMID- 27231330 OWN - NLM STAT- MEDLINE DCOM- 20170501 LR - 20211204 IS - 1521-0111 (Electronic) IS - 0026-895X (Print) IS - 0026-895X (Linking) VI - 90 IP - 2 DP - 2016 Aug TI - Glutamate Delta-1 Receptor Regulates Metabotropic Glutamate Receptor 5 Signaling in the Hippocampus. PG - 96-105 LID - 10.1124/mol.116.104786 [doi] AB - The delta family of ionotropic glutamate receptors consists of glutamate delta-1 (GluD1) and glutamate delta-2 receptors. We have previously shown that GluD1 knockout mice exhibit features of developmental delay, including impaired spine pruning and switch in the N-methyl-D-aspartate receptor subunit, which are relevant to autism and other neurodevelopmental disorders. Here, we identified a novel role of GluD1 in regulating metabotropic glutamate receptor 5 (mGlu5) signaling in the hippocampus. Immunohistochemical analysis demonstrated colocalization of mGlu5 with GluD1 punctas in the hippocampus. Additionally, GluD1 protein coimmunoprecipitated with mGlu5 in the hippocampal membrane fraction, as well as when overexpressed in human embryonic kidney 293 cells, demonstrating that GluD1 and mGlu5 may cooperate in a signaling complex. The interaction of mGlu5 with scaffold protein effector Homer, which regulates mechanistic target of rapamycin (mTOR) signaling, was abnormal both under basal conditions and in response to mGlu1/5 agonist (RS)-3,5-dihydroxyphenylglycine (DHPG) in GluD1 knockout mice. The basal levels of phosphorylated mTOR and protein kinase B, the signaling proteins downstream of mGlu5 activation, were higher in GluD1 knockout mice, and no further increase was induced by DHPG. We also observed higher basal protein translation and an absence of DHPG-induced increase in GluD1 knockout mice. In accordance with a role of mGlu5-mediated mTOR signaling in synaptic plasticity, DHPG-induced internalization of surface alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor subunits was impaired in the GluD1 knockout mice. These results demonstrate that GluD1 interacts with mGlu5, and loss of GluD1 impairs normal mGlu5 signaling potentially by dysregulating coupling to its effector. These studies identify a novel role of the enigmatic GluD1 subunit in hippocampal function. CI - Copyright (c) 2016 by The American Society for Pharmacology and Experimental Therapeutics. FAU - Suryavanshi, Pratyush S AU - Suryavanshi PS AD - Department of Pharmacology, Creighton University, Omaha, Nebraska. FAU - Gupta, Subhash C AU - Gupta SC AD - Department of Pharmacology, Creighton University, Omaha, Nebraska. FAU - Yadav, Roopali AU - Yadav R AD - Department of Pharmacology, Creighton University, Omaha, Nebraska. FAU - Kesherwani, Varun AU - Kesherwani V AD - Department of Pharmacology, Creighton University, Omaha, Nebraska. FAU - Liu, Jinxu AU - Liu J AD - Department of Pharmacology, Creighton University, Omaha, Nebraska. FAU - Dravid, Shashank M AU - Dravid SM AD - Department of Pharmacology, Creighton University, Omaha, Nebraska ShashankDravid@creighton.edu. LA - eng GR - R21 MH098270/MH/NIMH NIH HHS/United States PT - Journal Article DEP - 20160526 PL - United States TA - Mol Pharmacol JT - Molecular pharmacology JID - 0035623 RN - 0 (Protein Isoforms) RN - 0 (Receptor, Metabotropic Glutamate 5) RN - 0 (Receptors, Glutamate) RN - 0 (Receptors, Metabotropic Glutamate) RN - 0 (glutamate receptor delta 1) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) SB - IM MH - Animals MH - Gene Deletion MH - Hippocampus/*metabolism MH - Immunoprecipitation MH - Mice, Knockout MH - Models, Biological MH - Phosphorylation MH - Protein Binding MH - Protein Isoforms/metabolism MH - Proto-Oncogene Proteins c-akt/metabolism MH - Receptor, Metabotropic Glutamate 5/*metabolism MH - Receptors, Glutamate/*metabolism MH - Receptors, Metabotropic Glutamate/metabolism MH - Signal Transduction MH - TOR Serine-Threonine Kinases/metabolism PMC - PMC4959088 EDAT- 2016/05/28 06:00 MHDA- 2017/05/02 06:00 PMCR- 2017/08/01 CRDT- 2016/05/28 06:00 PHST- 2016/04/19 00:00 [received] PHST- 2016/05/24 00:00 [accepted] PHST- 2016/05/28 06:00 [entrez] PHST- 2016/05/28 06:00 [pubmed] PHST- 2017/05/02 06:00 [medline] PHST- 2017/08/01 00:00 [pmc-release] AID - mol.116.104786 [pii] AID - MOL_104786 [pii] AID - 10.1124/mol.116.104786 [doi] PST - ppublish SO - Mol Pharmacol. 2016 Aug;90(2):96-105. doi: 10.1124/mol.116.104786. Epub 2016 May 26.